dc.creatorRada, Elsa
dc.creatorUlrich, Mariam
dc.creatorAranzazu, Nacarid
dc.creatorSantaella, Carlos
dc.creatorGallinoto, Maria Eugenia
dc.creatorCenteno, Marta
dc.creatorRodriguez, Vestalia
dc.creatorConvit, Jacinto
dc.date2015-11-24T16:58:44Z
dc.date2015-11-24T16:58:44Z
dc.date1994-07-28
dc.date.accessioned2022-10-28T01:17:09Z
dc.date.available2022-10-28T01:17:09Z
dc.identifierhttp://hdl.handle.net/10872/12892
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4946586
dc.descriptionIn this study, we have evaluated the response of patients submitted to immunotherapy (IMT) with this combined vaccine together with multidrug therapy (MDT) during a 5- to lO-year period. Based on the use of multiple criteria, we have been able to analyze the diverse manifestations ofthe immune responses in these patients, most of whom had multibacillary disease. The parameters evaluated included determinations ofthe levels ofantibodies against PGLI, lymphocyte transformation assays, bacterial indexes and intradermal tests before each IMT treatment and at regular intervals for a period of at least 5 years.
dc.languageen
dc.publisherInternational Journal of Leprosy 62(4):552-558
dc.subjectImmunologic reactivity
dc.subjectleprosy
dc.subjectimmunotherapy
dc.titleA longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy
dc.typeArticle


Este ítem pertenece a la siguiente institución